Schizophrenia trials in Hong Kong
1 of 7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
- Where
- Hong Kong
- Age
- 18 years to 65 years
- People
- 40
- Run by
- Dr. Albert Kar-Kin Chung
See details and how to joinNCT05962216